Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 411-410-8 | CAS number: 118562-73-5
Endpoint summary
Administrative data
Description of key information
The LD50 value for male and female animals p.o. is greather than 10 000 mg/kg bw.
The LD50 value for male and female animals dermal is greather than 2 000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 10 000 mg/kg bw
- Quality of whole database:
- Test according to OECD guideline 401 and according to the OECD-GLP regulations, fixed in the Chemikaliengesetz 1990, but lack of data on the purity / quality of the sample tested.
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Test according to OECD guideline 402 and according to the OECD-GLP regulations, fixed in the Chemikaliengesetz 1990, but lack of data on the purity / quality of the sample tested.
Additional information
The acute oral toxicity of Hydroxyambran was determined according to the OECD Test Guideline 401 in a limit test with 10 000 mg/kg bw in rats.
No animals died during the course of the study.
Abnormal clinical signs were observed only within 1h - 48h p.a.
Weight gains were normal in all animals.
Gross pathological examinations at 14 days p.a. (terminal necropsy) revealed no test article-dependent findings.
The LD50 value for male and female animals p.o. is greather than 10 000 mg/kg bw.
The acute dermal toxicity of Hydroxyambran was determined according to the OECD Test Guideline 402 in a limit test with 2 000 mg/kg bw in rats.
No animals died during the course of the study.
No abnormal clinical signs were observed.
Weight gains were normal in all animals.
Gross pathological examinations at 14 days p.a. (terminal necropsy) revealed no test article-dependent findings.
The LD50 value for male and female animals dermal is greather than 2 000 mg/kg bw.
Justification for selection of acute toxicity – oral endpoint
Only abnormal clinical signs were observed within 1h - 48h p.a, not any other adverse effect was observed.
No animals died during the course of the study using a dosis of 10 000 mg/kg bw.
Justification for selection of acute toxicity – dermal endpoint
Apart from slight erythema and oedeme in one female animal on the administration area until day 2, not any other adverse effect was observed.
No animals died during the course of the study using a dosis of 2 000 mg/kg bw.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
